Cystic fibrosis (CF) is an autosomal ... and bronchiectasis with resulting marked decline in pulmonary function. The only treatment for end-stage CF lung disease is lung transplantation.

Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...

Thus, in the early stage, it is often misdiagnosed as ... preventing or slowing the progression of the disease. Pulmonary fibrosis is an end outcome of a variety of insults to the lung and is ...

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...

New York, USA, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Pulmonary Fibrosis Clinical Trial Pipeline Appears Robust With 110+ Key Pharma Companies Actively Working in the Therapeutics Segment ...

An international team of researchers has, for the first time, created a detailed map of the location and identity of individual cells in the adult lung, both from healthy lungs and in lungs from ...

(MENAFN- GlobeNewsWire - Nasdaq) The pulmonary fibrosis market is driven by the increasing prevalence of pulmonary fibrosis, especially idiopathic pulmonary fibrosis (IPF), among the aging ...